OverviewChartProfileKey statisticsFinancialsNewsTraderScreen

U.C.A. AG O.N./  DE000A12UK57  /

Frankfurt
2024-07-29  8:01:32 AM Chg. +0.6000 Volume Bid8:32:02 PM Ask8:32:02 PM Market Capitalization Dividend Y. P/E Ratio
29.0000EUR +2.11% 0
Turnover: 0.0000		 -Bid Size: - -Ask Size: - 19.2 mill.EUR 11.79% 7.23
GlobeNewswire 2023-12-22 Austal USA receives Expeditionary Medical Ship (EMS) contract award from U.S. Navy
GlobeNewswire 2021-10-01 Amolyt Pharma Announces Positive Data from Phase 1 Trial of AZP-3601 at the American Society for Bon...
TeleTrader 2021-01-06 Lockheed, DoD reach $1.3B deal on F-35 jets
GlobeNewswire 2020-02-25 Nobel Laureate Dr. Stanley Whittingham to Keynote G&W and Miller Thomson Li-ion Battery Materials Su...
GlobeNewswire 2018-05-09 Inovio Pharmaceuticals Reports 2018 First Quarter Financial Results
GlobeNewswire 2018-05-08 Patient Expectations Driving Growth in On-Demand Care
GlobeNewswire 2018-03-02 Herantis Pharma Plc's Financial Statements Release January 1 - December 31, 2017
GlobeNewswire 2017-10-23 GB Sciences Obtains Exclusive Worldwide License on a Time-Released Cannabinoid Formulation for Neuro...
GlobeNewswire 2017-10-17 US and International Patents Available for Ur24: Breakthrough Non-Invasive Urinary Catheter
GlobeNewswire 2017-08-29 Herantis Pharma Plc's half year financial report January 1 - June 30, 2017 (unaudited)
GlobeNewswire 2017-02-28 Herantis Pharma Plc's Financial Statements Release January 1-December 31, 2016
GlobeNewswire 2016-10-10 Kunwar B. Kishore Arora joins APCER Life Sciences as first Global Chief Operating Officer
GlobeNewswire 2015-03-11 Herantis Pharma's Phase 2 Dry Eye study recruitment completed ahead of schedule
GlobeNewswire 2015-02-27 Herantis Pharma financial statements report 2014
GlobeNewswire 2015-01-07 Herantis Pharma has initiated Phase 2 study with Cis-UCA Eye Drops in Patients with Dry Eye Syndrome...
GlobeNewswire 2014-09-08 Herantis Pharma announces FDA clearance of IND for Phase 2 study of Cis-UCA Eye Drops
GlobeNewswire 2007-11-15 U.C.A. AG: Quarterly results up to 30.09.2007 in accordance with the German Commercial Code (HGB)
GlobeNewswire 2007-08-29 U.C.A. AG: Half year results up to 30.06.2007 in accordance with the German Commercial Code (HGB)
GlobeNewswire 2007-05-15 U.C.A. AG: Quarterly results up to 31.03.2007 in accordance with the German Commercial Code (HGB)
GlobeNewswire 2007-05-15 U.C.A. AG: Final results up to 31.12.2006 and dividend proposal of Euro 1.30 per share
GlobeNewswire 2007-03-01 U.C.A. AG: Interim results up to 31.12.06 in accordance with the German Commercial Code (HGB)
GlobeNewswire 2006-11-07 U.C.A. AG: Results as at 30th September, 2006 according to the German Commercial Code (HGB)
GlobeNewswire 2006-08-18 U.C.A. AG: Halfyear results as at 30th June, 2006 according to HGB
GlobeNewswire 2006-05-19 U.C.A. AG: Interim results up to 31.03.06 in accordance with the German Commercial Code (HGB)
GlobeNewswire 2006-05-19 U.C.A. AG: Final results up to 31.12.05 in accordance with the German Commercial Code (HGB)